SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-032354
Filing Date
2019-02-08
Accepted
2019-02-08 16:49:30
Documents
2
Group Members
ONYX PHARMACEUTICALS, INC.ONYX THERAPEUTICS, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d702271dsc13g.htm SC 13G 62816
2 EX-99.1 d702271dex991.htm EX-99.1 5294
  Complete submission text file 0001193125-19-032354.txt   69838
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Subject) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90539 | Film No.: 19580619
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1